HUTCHMED (HCM) Competitors GBX 213 +10.00 (+4.93%) As of 11:53 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock HCM vs. SOPH, ITH, GRI, INDV, SLS, ERGO, BMY, SLN, AMYT, and OGNShould you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Sophos Group plc (SOPH.L) (SOPH), Ithaca Energy (ITH), Grainger (GRI), Indivior (INDV), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Bloomsbury Publishing (BMY), Silence Therapeutics (SLN), Amryt Pharma (AMYT), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry. HUTCHMED vs. Sophos Group plc (SOPH.L) Ithaca Energy Grainger Indivior Standard Life UK Smaller Companies Trust Ergomed Bloomsbury Publishing Silence Therapeutics Amryt Pharma Origin Enterprises Sophos Group plc (SOPH.L) (LON:SOPH) and HUTCHMED (LON:HCM) are both mid-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, community ranking, institutional ownership and valuation. Which has higher earnings and valuation, SOPH or HCM? Sophos Group plc (SOPH.L) has higher earnings, but lower revenue than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSophos Group plc (SOPH.L)£726.90M0.00N/A£1.70N/AHUTCHMED£771.01M3.00-£52.98M-£3.92-54.36 Is SOPH or HCM more profitable? Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to HUTCHMED's net margin of -6.87%. Sophos Group plc (SOPH.L)'s return on equity of 0.00% beat HUTCHMED's return on equity.Company Net Margins Return on Equity Return on Assets Sophos Group plc (SOPH.L)N/A N/A N/A HUTCHMED -6.87%-5.71%-5.90% Do institutionals and insiders have more ownership in SOPH or HCM? 36.5% of HUTCHMED shares are held by institutional investors. 39.0% of HUTCHMED shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor SOPH or HCM? In the previous week, Sophos Group plc (SOPH.L)'s average media sentiment score of 0.00 equaled HUTCHMED'saverage media sentiment score. Company Overall Sentiment Sophos Group plc (SOPH.L) Neutral HUTCHMED Neutral Does the MarketBeat Community prefer SOPH or HCM? Sophos Group plc (SOPH.L) received 221 more outperform votes than HUTCHMED when rated by MarketBeat users. Likewise, 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote while only 78.40% of users gave HUTCHMED an outperform vote. CompanyUnderperformOutperformSophos Group plc (SOPH.L)Outperform Votes41780.19% Underperform Votes10319.81%HUTCHMEDOutperform Votes19678.40% Underperform Votes5421.60% SummarySophos Group plc (SOPH.L) beats HUTCHMED on 7 of the 10 factors compared between the two stocks. Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCM vs. The Competition Export to ExcelMetricHUTCHMEDDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£2.31B£2.17B£5.35B£2.68BDividend Yield4.63%2.92%5.22%5.05%P/E Ratio-54.364.0126.58134.32Price / Sales3.00529.96391.69203,702.45Price / Cash2.4910.2538.2528.02Price / Book2.446.926.793.79Net Income-£52.98M£20.70B£3.23B£5.89B7 Day Performance4.93%0.47%4.03%7.78%1 Month Performance0.47%5.23%12.50%29.45%1 Year Performance-32.38%90.99%16.73%119.74% HUTCHMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCMHUTCHMEDN/AGBX 213+4.9%N/A-37.3%£2.31B£771.01M-54.361,760News CoverageSOPHSophos Group plc (SOPH.L)N/AN/AN/AN/A£2.99B£726.90M341.41520ITHIthaca EnergyN/AGBX 141.79+1.3%N/A+9.5%£2.96B£3.55B16.19220Trending NewsGRIGrainger2.7941 of 5 starsGBX 215+0.9%GBX 317.50+47.7%-11.1%£1.59B£276.05M-1,433.33372Earnings ReportDividend IncreaseINDVIndivior1.7151 of 5 starsGBX 840.87-0.6%GBX 1,650+96.2%-35.9%£1.31B£1.40B-697.211,000SLSStandard Life UK Smaller Companies TrustN/AN/AN/AN/A£715.41M£222.48M3.3710ERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386BMYBloomsbury Publishing3.1019 of 5 starsGBX 621-0.5%GBX 825+32.9%+6.2%£501.10M£382.40M13.2934,300News CoverageSLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownOGNOrigin EnterprisesN/AGBX 3.55flatN/A+18.9%£374.84M£183.08B10.2610,000Dividend Increase Related Companies and Tools Related Companies SOPH Competitors ITH Competitors GRI Competitors INDV Competitors SLS Competitors ERGO Competitors BMY Competitors SLN Competitors AMYT Competitors OGN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HCM) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.